Intuniv and Syncope aggravated - a phase IV clinical study of FDA data
Summary:
Syncope aggravated is reported as a side effect among people who take Intuniv (guanfacine hydrochloride), especially for people who are male, 10-19 old, have been taking the drug for < 1 month also take Prozac, and have Asthma.
The phase IV clinical study analyzes which people have Syncope aggravated when taking Intuniv. It is created by eHealthMe based on reports of 3,469 people who have side effects when taking Intuniv from the FDA, and is updated regularly.
What is Intuniv?
Intuniv has active ingredients of guanfacine hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 3,959 Intuniv users. Check the latest studies of Intuniv.
What is Syncope aggravated?
Syncope aggravated (a loss of consciousness with an inability to maintain postural tone) is found to be associated with 1,688 drugs and 590 conditions by eHealthMe. Check the latest studies of Syncope aggravated.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
3,469 people reported to have side effects when taking Intuniv.
Among them, 155 people (4.47%) have Syncope aggravated.
Among these 155 people:
How long have people been on Intuniv when they have Syncope aggravated? *
What is the gender of people who have Syncope aggravated when taking Intuniv? *
What is the age of people who have Syncope aggravated when taking Intuniv? *
What are other drugs people take besides Intuniv? *
What are other side effects people have besides Syncope aggravated? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Intuniv and have Syncope aggravated?
- Check whether Syncope aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Intuniv:
- Intuniv (3,959 reports)
Syncope aggravated treatments and more:
- Syncope aggravated (17 reports)
How severe was Syncope aggravated and when was it recovered:
Expand to all the drugs that have ingredients of guanfacine hydrochloride:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Intuniv:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Syncope aggravated:
- Syncope aggravated (1,688 drugs)
Browse all the conditions that are associated with Syncope aggravated:
- Syncope aggravated (590 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on guanfacine hydrochloride (the active ingredients of Intuniv) and Intuniv (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Tolterodine and Weakness for Women aged 60+ - a second ago
- Tolterodine and Asthenia for Women aged 60+ - a second ago
- Tolterodine and Muscle Fatigue for Women aged 60+ - a second ago
- Tolterodine and Muscular Weakness for Women aged 60+ - a second ago
- Tolterodine and Muscle Weakness for Women aged 60+ - 2 seconds ago
- Tolterodine and Lack Of Strength for Women aged 60+ - 2 seconds ago
- Tolterodine and Lack Of Strength, Muscle Weakness, Weakness for Women aged 60+ - 2 seconds ago
- Could Sennosides cause Oedema Peripheral? - 6 seconds ago
- Lorazepam and Avastin drug interactions for men aged 30-39 - 11 seconds ago
- Tysabri and Cardiac Disorder for Women aged 60+ - 13 seconds ago